# Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer

> **NCT00742222** · PHASE4 · COMPLETED · sponsor: **Xoft, Inc.** · enrollment: 63 (actual)

## Conditions studied

- Breast Cancer
- Carcinoma
- Lumpectomy
- Ductal Carcinoma in Situ

## Interventions

- **RADIATION:** Electronic Brachytherapy
- **RADIATION:** Intracavitary accelerated partial breast irradiation

## Key facts

- **NCT ID:** NCT00742222
- **Lead sponsor:** Xoft, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2016-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00742222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00742222, "Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00742222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*